S. Koder

发表

Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation.

I. Pabinger, C. Ay, G. Kornek, 2014, Translational research : the journal of laboratory and clinical medicine.

Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden.

P. Kyrle, C. Mannhalter, I. Pabinger, 2000, The hematology journal : the official journal of the European Haematology Association.

Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS).

I. Pabinger, T. Perkmann, C. Ay, 2015, Blood.

Thrombin‐generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause

H. Haslacher, A. Wolberg, I. Pabinger, 2019, Journal of thrombosis and haemostasis : JTH.

P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism

A. Kaider, C. Mannhalter, I. Pabinger, 2008, Thrombosis and Haemostasis.

Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study.

C. Marosi, D. Dunkler, C. Zielinski, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant.

A. Kaider, C. Mannhalter, I. Pabinger, 2007, Clinical chemistry.

A new measure for in vivo thrombin activity in comparison with in vitro thrombin generation potential in patients with hyper- and hypocoagulability

I. Pabinger, C. Ay, S. Panzer, 2016, Clinical and Experimental Medicine.

Clinical significance of anti-protein Z antibodies in patients with lupus anticoagulant.

A. Kaider, I. Pabinger, P. Quehenberger, 2008, Thrombosis research.

The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant.

C. Male, I. Pabinger, P. Quehenberger, 2007, Thrombosis research.

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).

C. Marosi, O. Wagner, D. Dunkler, 2007, Blood.

Association of platelet activation markers with cancer-associated venous thromboembolism

C. Marosi, A. Kaider, C. Zielinski, 2016, Platelets.

Low extracellular vesicle–associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis

N. Mackman, I. Pabinger, C. Ay, 2018, Annals of Hematology.

Association of elevated soluble P-selectin levels with fetal loss in women with a history of venous thromboembolism.

A. Kaider, P. Husslein, I. Pabinger, 2012, Thrombosis research.

High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant.

I. Pabinger, L. Kuessel, T. Perkmann, 2019, Blood advances.

Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals

I. Pabinger, C. Brostjan, C. Ay, 2020, Rheumatology.

The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study

A. Kaider, R. Bartsch, C. Zielinski, 2019, Research and practice in thrombosis and haemostasis.

Platelet activation and function during eltrombopag treatment in immune thrombocytopenia

I. Pabinger, C. Ay, S. Panzer, 2011, Annals of Hematology.

PO-63 - Exhausted platelets in cancer patients with high risk of venous thromboembolism and poor prognosis.

C. Marosi, A. Kaider, G. Prager, 2016, Thrombosis research.

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

A. Kaider, H. Haslacher, C. Mannhalter, 2016, Annals of Hematology.

Emicizumab for the Treatment of Acquired Hemophilia_A: Lessons Learned from 4 Very Different Cases

W. Sperr, T. Staudinger, K. Gleixner, 2018, Blood.

Emicizumab for the Treatment of Acquired Hemophilia A: Lessons Learned from 4 very Different Cases

W. Sperr, T. Staudinger, K. Gleixner, 2018, Hämostaseologie.

Alterations of blood coagulation in controlled human malaria infection

S. Hoffman, B. Mordmüller, P. Kremsner, 2016, Malaria Journal.

Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant

J. Rand, I. Pabinger, C. Ay, 2017, BMC Medicine.

Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A

F. Rosendaal, C. Mannhalter, I. Pabinger, 2004, Journal of thrombosis and haemostasis : JTH.

Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS)

G. Zlabinger, C. Zielinski, I. Pabinger, 2015, Clinical Cancer Research.

Lupus anticoagulant test persistence over time and its associations with future thrombotic events

I. Pabinger, C. Ay, P. Quehenberger, 2022, Blood advances.

Thrombin generation in patients with a bleeding tendency of unknown origin

I. Pabinger, C. Ay, C. Laczkovics, 2011, Annals of Hematology.

Altered platelet proteome in lupus anticoagulant (LA)-positive patients—protein disulfide isomerase and NETosis as new players in LA-related thrombosis

I. Pabinger, A. Assinger, M. Zellner, 2020, Experimental & Molecular Medicine.

Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease

G. Schernthaner, I. Pabinger, C. Ay, 2012, European journal of clinical investigation.

Altered platelet proteome in lupus anticoagulant (LA)-positive patients—protein disulfide isomerase and NETosis as new players in LA-related thrombosis

J. Basílio, I. Pabinger, A. Assinger, 2020, Experimental & Molecular Medicine.

High Levels of Soluble P-Selectin Are Associated with the Risk of Venous Thromboembolism and the P-Selectin Thr715 Variant.

A. Kaider, C. Mannhalter, I. Pabinger, 2006 .

Alterations of blood coagulation in controlled human malaria infection

Michael Ramharter, S. Hoffman, B. Mordmüller, 2016, Malaria Journal.